We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Naltrexone Reduces Risk of Hospitalization Due to Alcohol Use Disorder

News   Jan 18, 2021 | Original story from the University of Eastern Finland

 
Naltrexone Reduces Risk of Hospitalization Due to Alcohol Use Disorder

Credit: Jeff Siepman, Unsplash

 
 
Advertisement
 

RELATED ARTICLES

Chronic Skin Inflammation Molecular Mechanisms Identified

News

Researchers have identified new molecular mechanisms as causes for chronic skin inflammation like in atopic dermatitis (AD or neurodermatitis) and psoriasis that could provide suitable starting points for new therapies.

READ MORE

NIH Closes Enrolment for Two Sub-Studies in ACTIV-3 Trial

News

The ACTIV-3 clinical trial, which is evaluating the safety and efficacy of investigational therapeutics for COVID-19 in hospitalized patients, has closed enrolment in two sub-studies. The first sub-study was examining the investigational monoclonal antibody therapy VIR-7831 and the second was evaluating a combined monoclonal antibody therapy containing BRII-196 and BRII-198.

READ MORE

Probing the Proteomic Landscape of Cancer To Discover Drug Targets

News

Researchers have shown that analysis of the proteomics, or all the protein data, from aggressive human cancers is a valuable strategy to identify potential novel therapeutic targets.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE